More about

Leukemia

News
November 05, 2021
4 min read
Save

Experts discuss management of cancer therapies in the era of COVID-19

Experts discuss management of cancer therapies in the era of COVID-19

Management of cancer therapies in the era of COVID-19 infection and vaccination requires careful consideration of both disease and patient characteristics, according to members of a crossfire panel at Chemotherapy Foundation Symposium.

News
November 04, 2021
1 min read
Save

Treatment landscape ‘exciting’ for patients with acute lymphoblastic leukemia, expert says

Treatment landscape ‘exciting’ for patients with acute lymphoblastic leukemia, expert says

Significant progress has been made in treatment and improving survival outcomes across all subtypes of acute lymphoblastic leukemia, according to a speaker at Chemotherapy Foundation Symposium.

News
November 04, 2021
2 min read
Save

CAR T-cell therapy linked to cardiovascular, pulmonary adverse effects

CAR T-cell therapy linked to cardiovascular, pulmonary adverse effects

Chimeric antigen receptor T-cell therapy appeared associated with various cardiovascular and pulmonary adverse events, according to results of a retrospective pharmacovigilance study.

News
November 04, 2021
1 min read
Save

FDA grants orphan drug designation to SEL24/MEN1703 for AML

FDA grants orphan drug designation to SEL24/MEN1703 for AML

The FDA granted orphan drug designation to SEL24/MEN1703 for the treatment of acute myeloid leukemia.

News
November 03, 2021
3 min read
Save

Next-generation sequencing to impact all aspects of care for myelodysplastic syndrome

Next-generation sequencing to impact all aspects of care for myelodysplastic syndrome

Incorporation of next-generation sequencing into standard of practice will be required for patients with myelodysplastic syndrome and will impact all facets of care, according to a presenter at Chemotherapy Foundation Symposium.

News
October 29, 2021
1 min read
Save

ASH announces new executive committee members

ASH announces new executive committee members

Three individuals have been elected to American Society of Hematology’s executive committee.

News
October 29, 2021
1 min read
Save

FDA approves Scemblix for certain patients with chronic myeloid leukemia

FDA approves Scemblix for certain patients with chronic myeloid leukemia

The FDA approved asciminib for treatment of certain patients with chronic myeloid leukemia, according to a press release from the agent’s manufacturer.

News
October 28, 2021
4 min read
Save

Earlier CAR-T treatment possible if price comes down, FDA official says

Earlier CAR-T treatment possible if price comes down, FDA official says

Expanded use of chimeric antigen receptor T cells for cancer treatment requires that less expensive therapies be developed faster using multiple manufacturing models, according to an FDA official.

News
October 26, 2021
2 min read
Save

FDA clears application for anti-PD-1 CAR-T to treat hematologic, breast cancers

FDA clears application for anti-PD-1 CAR-T to treat hematologic, breast cancers

The FDA cleared an investigational new drug application for PRGN-3007, a chimeric antigen receptor T-cell therapy for patients with advanced hematologic malignancies or solid tumors that express receptor tyrosine kinase-like orphan receptor 1.

News
October 26, 2021
4 min read
Save

Cancer drug trials too slow, patients and families say in survey

Cancer drug trials too slow, patients and families say in survey

The sense of urgency surrounding the COVID-19 pandemic led to speedy development of several vaccines against the SARS-CoV-2 virus.

View more